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Maleic acid-induced impaired conversion of 25(OH)D3 to
1,25(OH)2D3: Implications for Fanconi's syndrome. Conversion of
25-hydroxyvitamin D3 [25(OH)D3] to I ,25-dihydroxyvitamin D3
[l,25(OH)2D3] occurs exclusively in the renal cortex. To determine
whether a disorder of the renal cortical tubule capable of causing
Fanconi's syndrome can also impair the synthesis of l,25(OH)2D3,
we investigated whether conversion of 25(OH)D3 to I ,25(OH)2D3
was reduced by maleic acid. In vitamin D-deficient rats, maleic
acid was administered iv. over two hours. Thirty minutes after its
initiation, when the complex renal tubule dysfunction had oc-
curred, 3H-25(OH)D3 was administered i.v. as a bolus. Five hours
afterwards, the amount of 3H-l,25(OH)2D3 recovered in the kid-
ney, small intestine mucosa, and blood was one-third to one-half
that in tissues of control rats that received acetazolamide or only
saline or were subjected only to the surgical procedure. The gb-
merular filtration rate, as measured by inulin clearance, did not
decrease significantly with maleic acid. In intact vitamin D-
deficient chicks, 24 and 22 hr after i.p. administration of maleic
acid and 14C-vitamin D3, respectively, the amount of 14C-
l,25(OH)2D3 recovered in small intestine mucosa was reduced by
one-half when compared to saline-treated controls. In kidney
homogenates and isolated renal tubules of vitamin D-deficient
chicks, activity of 25-hydroxyvitamin D3- 1 -hydroxylase was dimin-
ished immediately after maleic acid was administered in vivo or
added in vitro to the incubation medium, respectively. These data
provide the first demonstration that the renal capacity to convert
25(OH)D3 to l,25(OH)2D3 can be substantially impaired in vivo by
a renal disorder in which the glomerular filtration rate is not
reduced.
Alteration de Ia conversion de In 25-hydroxyvitamine D3 en 1,25-
dihydroxyvitamine D induite par I'acide maléique: Implications
dans le syndrome de Fanconi. La conversion de Ia 25-hydroxy-
vitamine D3 125(OH)D3] en 1,25-dihydroxyvitamine D3
ll,25(OH)2D31 est réalisée exclusivement dans les mitochondries
du cortex renal. Pour savoir si une lesion du tube renal cortical,
capable de créer un syndrome de Fanconi, peut aussi empêcher Ia
synthèse du I,25(OH)2D3 nous avons étudié Ia conversion du
25(Ol-l)D, en I,25(OH)2D3 chez des animaux traités par l'acide
malCique. L'administration de cet agent determine des dysfonc-
tionnements complexes du tube renal, semblables a ceux que l'on
observe dans le syndrome de Fanconi, et une inhibition du métabo-
lisme oxydatif des mitochondries rénales. L'acide maleique a été
administré a des rats carencés en vitamine D, par voje iv., sur une
période de deux heures. Trente minutes après Ic debut, quand les
dysfonctionnements tubulaires complexes sont apparus, du 8H-
25(OH)D3 a été administré par voie i.v. en une injection breve.
Cinq heures aprés, la quantitC du 'H-l,25(OH)2D3 récupCrée, dans
Ic rein, Ia muqueuse de l'intestin gréle et le sang, n'est que Ic tiers
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ou Ia moitió de celle obtenue chez des rats contrôles qui ont recu de
l'acétazolamide ou du solute sale, ou qui n'ont été soumis qu'au
protocole chirurgical. Le debit de filtration glomCrulaire, mesuré
par Ia clearance de l'inuline, ne diminue pas significativement avec
l'acide maléique. Chez des poulets intacts carencés en vitamine D
Ia quantité de '4C-l,25(OH)2D3 récupérée dans Ia muqueuse in-
testinale 24 et 22 hr aprés l'administration par voie i.p. d'acide
maléique et de 14C-vitamine D8 est réduite a Ia moitiC des valeurs
obtenues chez des contrôles qui ne reçoivent que du solute sale.
Dans les homogénats de reins et les tubes isolCs de rein de poulets
carencCs en vitamine D l'activité de Ia 25-hydroxyvitamine D3-I-
hydroxylase est diminuée immédiatement aprCs l'administration
d'acide maleique in vivo ou l'addition de l'acide in vitro au milieu
d'incubation. Ces résultats apportent Ia premiCre demonstration de
Ce que Ia capacité du rein a convertir Ic 25(OH)D3 en I,25(OH)2D3
peut être altCrée in viva par une lesion rénale au cours de laquelle Ia
filtration glomCrulaire n'est pas diminuée. Puisqu'il est connu que
l'acide maleique altère le métabolisme oxydatif des mitochondries
rénales isolCes, il est possible que l'action immediate d'inhibition
de Ia 1-hydroxylase des tubes rénaux isolCs soit Iiée a une alteration
directe du métabolisme mitochondrial.
Fanconi's syndrome consists of a renal disorder
characterized by a complex dysfunction of the prox-
imal renal tubule that includes impaired reabsorption
of amino acids, glucose, bicarbonate, and phosphate
and the presence of metabolic bone disease, either
rickets in children or osteomalacia in adults [1—3].
Although hypophosphatemia resulting from the renal
dysfunction is probably an important factor in the
pathogenesis of the bone disease [2], healing of the
bone disease can occur with no measured change in
the severity of the hypophosphatemia and character-
istically requires pharmacologic and often massive
amounts of vitamin D. 1,25-dihydroxyvitamin D3
[l,25(OH)2D3] is the biologically most active metab-
olite of vitamin D3, with respect to bone metabo-
lism [4, 5] and healing of rickets [6]. 1 ,25(OH)2D3 is
synthesized exclusively in mitochondria of the renal
cortex [7—9], by the 1-hydroxylation of 25-hydroxy-
vitamin D3 [25(OH)D3], which is synthesized princi-
pally in the liver [10]. Accordingly, it is possible that
by impairing either the 1-hydroxylation reaction per
se or the accession of 25(OH)D3 to the mitochondrial
site of the reaction, abnormalities of the renal cortical
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tubule capable of causing Fanconi's syndrome [3]
might reduce the renal synthesis of l,25(OH)2D3 and
contribute to the pathogenesis of the bone disease of
Fanconi's syndrome. In animals, the experimental
administration of maleic acid induces a reversible
renal tubule dysfunction like that of Fanconi's syn-
drome [11—16] and metabolic and structural changes
in the renal cortical tubules, particularly in the mito-
chondria [17—21]. In the present study, we report
evidence that in vitamin D-deficient rats and chicks,
maleic acid induces a substantial reduction in the
conversion of 25(OH)D3 to 1,25(OH)2D3, and this
reduction occurs without a significant decrease in
glomerular filtration rate, where measured in the rat.
Methods
Animals. Weanling male rats (Carworth Division
of Charles River Company) and one-day-old white
Leghorn cockerels (Cucamonga, CA) were raised in a
windowless room lighted only by a tungsten bulb.
They were fed vitamin D-deficient diets containing
0.44% calcium and 0.3% phosphorus (rats) [22] and
0.6% calcium and 0.4% phosphorus (chicks) [6]. Rats
were studied after 7 to 12 weeks on the diet when
hypocalcemic (serum calcium, 4 to 8 mg/l00 ml) and
hypophosphatemic (serum phosphorus, 2 to 3
mmoles/liter). Chicks were studied at four weeks
when rachitic.
Physiologic studies in rats. Eleven vitamin D-
deficient rats were studied while unanesthetized and
in a plexiglass restraining cage. Twenty-four to 72 hr
beforehand, polyethylene catheters were placed in the
left carotid artery and right external jugular vein,
according to the method of Harris and Felts [23], in
order to sample arterial blood repetitively and to
administer solutions intravenously at the time of
study.
Maleic acid (neutralized with sodium hydroxide to
a pH of 7.2), 200 mg/kg of body wt, or acetazola-
mide, 1 mg/kg of body wt, was administered i.v. over
two hours in solutions containing inulin (10 g/100
ml) and either glucose (2.5 mg/l00 ml) (maleic acid
only) or saline (0,45 g/100 ml) (maleic acid or aceta-
zolamide) at rates of 0.051 and 0.097 mI/mm, respec-
tively; carrier solutions were maintained at these rates
until the animals were killed. In rats receiving aceta-
zolamide, a solution of sodium bicarbonate (7.5
mEq/lOO ml) was administered at a rate calculated to
replace the urinary losses of bicarbonate measured
after each voiding. In all rats receiving saline, a 0.9
g/100 ml solution of saline was administered at 0.097
mI/mm for one hour immediately before initiating
either maleic acid or acetazolamide.
Throughout each study, urine samples were col-
lected continuously, under oil, from spontaneous
voidings into a glass tube, the superior rim of which
was maintained flush and constant against the rat's
abdominal wall. In each study, both before and dur-
ing administration of maleic acid or acetazolamide,
urine obtained from two to eight successive voidings
was pooled to comprise single clearance periods,
ranging in duration from 25 to 110 mm.
The glomerular filtration rate was measured by
inulin clearance. Plasma and urinary inulin clear-
ances were measured by the anthrone method [24];
plasma and urinary phosphorus concentrations, by
the method of Fiske and Subbarow [25]; urinary a-
amino nitrogen concentration, by a combination of
the methods of Khachadurian et al [26] and Moore
and Stein [27]; urinary sodium and potassium con-
centrations, by standard flame photometry; serum
calcium concentration, with an atomic absorption
spectrophotometer (Perkin-Elmer); urinary total car-
bon dioxide content, by a microgasometer (Natelson,
model 600); and arterial pH and carbon dioxide ten-
sion and urinary pH, with a pH meter (Radiometer
pH Meter 26) with a gas monitor. Plasma and
urinary bicarbonate concentrations were calculated
as described previously [28].
3H-25(OH)D3 metaboliles in rats. In each of the 11
rats, 625 pmoles (0.25tg) of 25-hydroxy-[26, 27-3H]
vitamin D3 (specific activity, 545,000 dpm/nmole;
New England Nuclear, Boston, MA) in 0.1 ml of
1,2-propanediol was administered i.v. as a bolus
after a dysfunction of the renal tubule had been
initiated 30 mm earlier with either i.v. administered
maleic acid (seven rats) or acetazolamide (four
rats). In eight additional rats, the radioactive ma-
terial was administered either immediately after
administration of 0.9 g/100 ml saline at 0.097
mi/mm for one hour (four rats) or one day after
the surgical procedure only (four rats). Five hours
after administration of the labeled material, the
animals were killed by decapitation, and specimens of
kidney, small intestine mucosa, and whole blood
were obtained for measurements of metabolites of
3H-25(OH)D3. The chloroform-extractable fraction
of each tissue, prepared by the method of Bligh and
Dyer [29], was dried under nitrogen gas and chro-
matographed on Sephadex LH-20, 1 X 60-cm col-
umns, as described by Holick and DeLuca [30]. '4C-
25(OH)D3 and '4C-l,25(OH)2D3 standards, obtained
from the lipid extract of vitamin D-deficient chick
small intestine mucosa, were co-chromatographed
with each sample [31]. Radioactivity of successively
collected fractions (4 mI/fraction) was counted to 2%
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error in PBD toluene counting solution [5 g of 2-
phenyl-5(4-biphenyi)-l,3,4-oxadiazol in one liter of
toluene] by a liquid scintillation counter (Tricarb
3385, Packard). Subsequent calculations were made
on a calculator (Hewlett Packard 9810).
After drying and resuspension in 1 ml of methanol,
some samples were incubated with 0.33 ml of sodium
periodate (5 g/100 ml) for four hours [32], extracted
again with chloroform-water (3: 1), and subsequently
chromatographed on Sephadex LH-20, 1 X 60-cm
columns [30]. Radioactivity of successively collected
fractions was determined as above. The procedure
with sodium periodate was carried out because Seph-
adex LH-20 column chromatography does not sepa-
rate l,25(OH)2D3 from 25,26-dihydroxyvitamin D3
[25,26(OH)2D3]. Prior incubation of tissue sam-
ples with sodium periodate will remove
25,26(OH)2D3 by cleavage of the C-25-C-26 bond
containing vicinyl hydroxyl groups; 1,25(OH)2D3
should not be affected by periodate incubation. Using
this procedure of periodate incubation, we recovered
>90% of the 3H-l,25(OH)2D3 in the lipid extract of
vitamin D-deficient chick kidney homogenates.
25( OH)D3-1 -hydroxylase activity in chick kidney
homogenates. Five groups of three vitamin D-
deficient chicks were killed at times ranging from 0 to
48 hr after 200 mg of maleic acid per kg of body wt
was administered intracardially. The kidneys were
immediately removed to 20 ml of ice-cold 15 m Iris-
hydrochloric acid buffer (p1-I, 7.4) containing 8.5 mrvi
magnesium chloride, 8.5 m sodium malate, and 200
m sucrose, and homogenized by three passes in a
homogenizer (Potter-Elvehjem). Separate homog-
enates were prepared from the kidneys of each chick.
1.7 nmoles of 25-hydroxy-[26,27-3H] vitamin D3(spe-
cific activity, 103,000 dpm/nmole; Amersham-Searle)
was added to 10 ml of each homogenate to initiate the
enzyme reaction. The activity of 1-hydroxylase was
determined by the method of Henry et al [33], using
Sephadex LH-20, 0.8 X 20-cm minicolumns. The rate
of production of 3H-l,25(OH)2D3 was determined for
each homogenate. Linearity of each assay was as-
sessed by determining the correlation coefficient r,
which was always >0.92. Protein concentration was
determined by the Biuret method [34].
25( OH)D,-l -hydroxylase activity in chick renal tu-
bules. Renal tubule suspensions were prepared from
the kidneys of six vitamin D-deficient chicks by a
modification of the method of Sham [35]. After pas-
sage through a layer of 80-tim nylon mesh, tubules
were collected by centrifugation for one minute at
750 X g at 0°C, washed twice by resuspension in 10
ml of Buffer T (0.05M Tris-hydrochloric acid buffer
[pH, 7.4] containing 2 mg/100 ml streptomycin sul.
fate, 15 mg/100 ml penicillin G, and 0.1 g/l00 ml
bovine serum albumin, recentrifuged for 1 mm
at 750 x g at 0°C, and suspended in a final volume of
15 ml of Buffer T supplemented with I m magne-
sium chloride and 5 m sodium malate. As described
by Sham and Barnea [36], metabolic integrity of th
renal tubules was demonstrated by their ability to
oxidize 14C-glucose to amounts of '4C02 that in-
creased linearly for 60 mm. In amounts required to
achieve final concentrations ranging from I to 20 mi,
maleic acid was added simultaneously with 0.87
nmole of 3H-25(OH)D3 (specific activity, 103,000
dpm/nmole) to 10 ml of renal tubule suspension; the
1-hydroxylase activity was determined by the method
described above. Duplicate assays were performed at
all concentrations of maleic acid.
'4C-vilamin D3 metabolizes in chicks. In each of
eight vitamin D-deficient chicks, 1.3 nmoles of
[4—'4C]—vitamin D3 (specific activity, 32.3 mCi/nmole;
Amersham-Searle) was administered i.p. two hours
after i.p. administration of either 200 mg/kg of ma-
leic acid (four chicks) or an equal volume of saline
(0.9 g/l00 ml) (four chicks). Twenty-two hours later,
chicks were killed by decapitation, and small intestine
mucosa from each of four chicks treated in the same
fashion was pooled for analysis of 14C-vitamiri D3
metabolites by the same methods as described in the
preceding for metabolites of 3H-25(OH)D3.
Statistics: The unpaired Student's t test was used
for statistical analysis of results.
Results
Within 30 mm of its initiation, maleic acid induced
a complex dysfunction of the renal tubule, like that of
patients with clinical Fanconi's syndrome, as evi-
denced by significant increases in the urinary excre-
tion rate of phosphate, a-amino nitrogen, and bi-
carbonate, and in the value of urinary pH (Fig. I).
The magnitude of the dysfunctions are similar to
those previously reported for maleic acid at the dose
employed [12, 14] and for non-vitamin D-deficient
rats raised on standard rat chow in our laboratory
(unpublished data). Within 30 mm of its initiation,
acetazolamide induced no increases in the urinary
excretion of a-amino nitrogen, but did induce
phosphaturia, bicarbonaturia, and natriuria of mag-
nitudes as great as or greater than those induced by
maleic acid (Fig. 1). All rats remained hypophospha-
temic (serum phosphorus, 2.03 0.25 mmoles/liter)
during the time of study. Arterial pH and plasma
bicarbonate concentration were normal (7.423
0.023 and 25.0 + 3.8 mEq/liter, respectively) at the
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Fig. I. The effect of maleic acid or acetazolamide administration on
renal function in vitamin D-deficient rats. The closed circles (.)
denote the mean values I so for seven rats receiving 200 mg/kg
maleic acid i.v. over two hours. The closed triangles (Y) denote the
mean values + I so for four rats receiving I mg/kg acetazolamide
iv. over two hours.
time of study, and did not increase significantly dur-
ing any of the infusion studies. Glomerular filtration
rate, as measured by inulin clearance, did not change
significantly in either group of rats when maleic acid
or acetazolamide was administered (Fig. 1).
In rats that received maleic acid, the amount of
3H detected in the chromatographic peak for
l,25(OH)2D3 in kidney, mucosa of small intestine,
and blood was one-third to one-half that detected in
these tissues in control rats which received acetazola-
mide or only saline or were subjected only to the
surgical procedure (Fig. 2). In the maleic acid-treated
rats, the mean values of 3H in the chromatographic
peak for I ,25(OH )2D3 in all three tissues studied were
significantly lower than those of the combined con-
trol group comprised of all control animals (Fig. 3).
After incubation of the lipid extract of each of these
three tissues with sodium periodate, the amount of
l,25(OH)2D3 recovered in tissues from maleic acid-
treated rats remained only half that recovered in
those from saline-treated rats. Accordingly, in the
maleic acid-treated rats, the reduction in amounts of
3H recovered in the chromatographic peak for
l,25(OH)2D3 could not be attributed to a reduction in
amounts of 25,26(OH)2D3.
The amount of 3H-25(OH)D3 measured in the
blood of maleic acid-treated rats did not differ from
that measured in the blood of control rats (66.8
23.1 pmoles/rat and 63.7 23.0 pmoles/rat, respec-
tively).
The percentage of radioactivity recovered as
25(OH)D3 and l,25(OH)2D3 from intestine mucosa
and blood in control rats in this study was similar to
the percentage of radioactivity recovered as those
metabolites in intestine mucosa nuclei and plasma in
vitamin D-deficient rats studied by Cousins, DeLuca,
and Gray [37].
In kidney homogenates of vitamin D-deficient
chicks, 1-hydroxylase activity was significantly di-
minished within one hour of administration of maleic
acid to the intact chick (Fig. 4); within four hours, the
activity was decreased to one-third of the control
value (Fig. 4). The values for 1-hydroxylase activity
in control chicks were similar to those previously
reported for vitamin D-deficient chicks [33].
When maleic acid and 3H-25(OH)D3 were added
simultaneously to suspensions of chick renal tubules,
1-hydroxylase activity decreased in a dose-dependent
fashion to values ranging from 86 to 7% that of
controls (Fig. 5).
In the intact vitamin D-deficient chicks that re-
ceived maleic acid as well as '4C-vitamin D3, the
amount of l,25(OH)2D3 recovered from small in-
testine mucosa was only one-half that of saline-
treated chicks (Fig. 6), demonstrating an anticipated
metabolic consequence of the maleic acid-induced
reduction of 1-hydroxylase activity.
Discussion
The results of this study demonstrate that in vita-
min D-deficient animals, the conversion of 25(OH)D3
to l,25(OH)2D3 can be reduced when the renal tubule
is disordered by an abnormality capable of causing a
complex dysfunction of the renal tubule, like that of
patients with the Fanconi syndrome, In rats in which
this complex renal dysfunction was induced with ma-
leic acid, the apparent conversion of 3H-25(OH)D3 to
3H-l,25(OH)2D3 was only one-half to one-third that
in control rats that received acetazolamide or saline,
or that were subjected only to surgery. In the kidney
of the maleic acid-treated rat, the amount of
l,25(OH)2D3 was only one-third that detected in the
kidney of the control group, and this difference was
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Fig. 2. Theeffect of maleic acid on conversion of H-25( OH)Da to 8H-1 ,25(OH)2D3 in vitamin D-
deficient rats. Samples obtained from two to three rats undergoing the same experimental
maneuver were pooled for column chromatography. Each value represents the mean of the
number of chromatographs indicated in parentheses.
highly significant (P < 0.005). This difference could
not be attributed to differences in the measured gb-
merular filtration rate. It might be argued that the
small, even though statistically insignificant, decrease
in measured glomerular filtration rate observed with
maleic acid could result in a substantial reduction in
0)
C
E
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the conversion of 25(OH)D3 to l,25(OH)2D3. But in
the vitamin D-deficient rat, reduced conversion did
not attend a 12-hr period of bilateral ureteral liga-
tion, despite the occurrence of azotemia of a degree
usually indicative of severe reduction in glomerular
filtration rate [38]. Furthermore, reduced conversion
Fig. 3. Theeffect ofmaleic acidon conversion of3H-25(OH)D3 to 3H-I,25(OH)2D3 in vitamin D-
deficient rats. The control group is comprised of all animals receiving acetazolamide, saline
alone, or subjected only to the surgical procedure as in Figure 2. The vertical lines (I) indicate
I su from the mean.
Kidney
12
10
Small intestine
mucosa
3.0
2.5
2.0
Maleic Controls
acid
P<0.05
Blood
Maleic Controls
acid
P < 0.05
0
8
6
4
2
0
ControlsMaleic
acid
P < 0.005
Maleic acid-induced impairment of 25(OH)D3 metabolism 249
/ 24 4'8
Time after maleic acid, hr
Fig. 4. Time course of the effect of intracardial administration of
maleic acid on the activity of 25(OH)D3-l-hydroxylase in kidney
homogenates from rachilic chicks. Each symbol and its brackets
represent the mean + I SD of three determinations made on
homogenates from three separate chicks. The activities at 1, 2, 4,
and 48 hr are all significantly less than that at zero time, the P
values being <0.025, <0.05, <0.005, and <0.001, respectively.
did not occur in patients with vitamin D-deficiency
and primary hyperparathyroidism, despite sub-
stantial reduction in glomerular filtration rate [39].
Indeed, reduced conversion of 25(OH)D3 to
l,25(OH)2D3 in vitamin D-deficient states has pre-
viously been demonstrated in vivo only in bilaterally
nephrectomized rats [38] and in patients with severe
reduction in renal mass, as judged by severe azo-
temia, and measured reduction in glomerular filtra-
tion rate [40]. Accordingly, the results of the present
study provide the first demonstration that the renal
capacity to convert 25(OH)D3 to l,25(OH)2D3 can be
substantially and directly impaired in vivo by a renal
disorder in which glomerular filtration rate and func-
tional renal mass are not reduced.
Reduced or "ineffective" renal synthesis of
l,25(OH)2D3 has recently been suggested as a critical
pathogenetic mechanism in the rickets/osteomalacia
of at least two clinical disorders in which glomerular
filtration rate and renal mass are characteristically
not reduced: vitamin D-dependency (VDD) [41, 42]
and pseudohypoparathyroidism (PsH) [43]. Al-
though there is no published direct evidence that
renal conversion of 25(OH)D3 to l,25(OH)2D3 is re-
duced in VDD [3], the finding in these patients that
"minute" amounts of i.v. administered l,25(OH)2D3
are curative of rickets is suggestive of this possibility
[41]. In each of three adult patients with PsH [43] in
whom the plasma concentration of l,25(OH)2D3 was
measured, the value was less than those measured in
normal subjects. Although this finding is "consistent
with an ineffective synthesis of l,25(OH)2D3" [43], it
does not constitute evidence of reduced renal syn-
thesis of l,25(OH)2D3. Furthermore, even if renal
conversion of 25(OH)D3 to l,25(OH)2D3 were re-
duced in patients with PsH, the reduction might be a
reversible consequence of the hyperphosphatemia
that is characteristic of this disorder [44].
The mechanism by which maleic acid causes a re-
duction in renal conversion of 25(OH)D3 to
l,25(OH)2D3 is not defined by the present study. It
seems unlikely, however, that the maleic acid-
induced, Fanconi-like, renal dysfunction per se
caused the impaired conversion of 25(OH)D3 to
l,25(OH)2D3. A priori, it could be argued that the
maleic acid-induced impairment in renal acidification
and phosphate reabsorption might affect cells of the
proximal tubule so as to alter their pH and concen-
tration of phosphate, both of which may be modu-
lators of the rate of conversion of 25(OH)D3 to
l,25(OH)2D3 [44—46]. But in the vitamin D-deficient
rat, an acetazolamide-induced renal dysfunction of
similar or greater magnitude with respect to reab-
sorption of bicarbonate and phosphate was not at-
tended by impaired conversion of 25(OH)D3 to
l,25(OH)2D3. It should also be noted that while 1-
hydroxylase activity has been localized to mito-
chondria of the renal cortex [7—9] and to isolated
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Fig. 5. Dose-response relationship of maleic acid and the activity of
25(OH)D.-l-hydroxylase determined in vitro in preparations of renal
tubules from rachitic chicks. The values of activities represented are
the means of two determinations on tubules pooled from six
chicks.
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renal tubule preparations [35, 45], the enzyme has not
been demonstrated in the proximal tubule.
In the intact rat, administered maleic acid accumu-
lates predominantly in the kidney [47] and, within
minutes of its administration, induces a complex dys-
function of the renal tubule like that of patients with
Fanconi's syndrome [13—15]. Maleic acid is known to
induce morphologic changes in renal cortical mito-
chondria at the dose administered in this study [19,
201 and to impair renal mitochondrial oxidative me-
tabolism in a variety of experimental preparations,
including that of isolated mitochondria [17]. The
conversion of 25(OH)D3 to 1,25(OH)2D3 occurs
uniquely in the mitochondria of the renal cortex
[7—9], and the enzyme catalyzing the conversion,
25(OH)D3-l-hydroxylase, is a mixed oxidase that re-
quires molecular oxygen [8]. Accordingly, the results
of the present study are consistent with the possibility
that maleic acid impairs the 1-hydroxylation reaction
by directly impairing mitochondrial metabolism.
Consistent with this possibility is the finding that
maleic acid induces a striking, immediate reduction
in 1-hydroxylase activity in the kidney of the vitamin
D-deficient chick, both when administered to the in-
tact chick or added in vitro to a renal tubule prepara-
tion.
The reduction in renal conversion of 25(OH)D3 to
l,25(OH)2D3 might be a consequence of impaired
accession of 25(OH)D3 to the mitochondrial site of
its hydroxylation. Bergeron and Laporte emphasized
that maleic acid induces profound structural changes
in the perimitochondrial membranes of the renal cor-
tical tubule [21]. These membranes are invaginations
of the basilar membrane that interdigitate with the
pallisades of mitochondria located at the base of the
renal tubular cell. One can envision that disruption
and disappearance of these membranes [21] could
restrict the accession of 25(OH)D3 to the 1-hy-
droxylase-containing mitochondria. Yet, the major
changes in these membranes were not noted until
24 hr after very large amounts of maleic acid (9
mmoles/kg) were administered. Similar changes were
not noted by Rosen et al [19] in renal tissues exam-
ined one hour after identical or smaller amounts (1.5
mmoles/kg) of maleic acid were administered. In-
deed, Roth, Hwang, and Segal [48] found no struc-
tural changes in fragments of rat renal tubules ex-
posed to maleic acid (6 mM) for 30 mm. Yet, impaired
transport had clearly occurred in these tubules. In the
intact rat, impaired renal tubular transport occurs
within five minutes of administering maleic acid at a
relatively small dose (0.9 mmole/kg) [13, 14]. In the
preparation of chick renal tubules employed in the
present study, the effect of maleic acid (I to 20 mM)
10 20 30 40 50 60 10 20 30 40 50 60
Fraction, 4 ml
Fig. 6. Chromatograms (Sephadex LH-20) of chloroform-soluble
metabolites of '4C-vitaniin D3 recovered in small intestine mucosa
from rachitic chicks to which maleic acid was (right panel) or was not
(left panel) administered i.p. 24 hr before tissue was sampled.
on conversion of 25(OH)D3 was noted within 20 mm.
Accordingly, it seems difficult to attribute this finding
to structural changes in the tubule that might restrict
the access of 25(OH)D3 to the mitochondrial site of
the 1-hydroxylation reaction.
Whatever its precise pathogenetic mechanism, the
fact that impaired conversion of 25(OH)D3 attends
an experimental dysfunction of the renal tubule, like
that of Fanconi's syndrome, may have clinical impli-
cations. Decreased production of I ,25(OH)2D3 or an-
other metabolite of 25(OH)D3 may contribute to the
pathogenesis of the bone disease characteristic of pa-
tients with clinical Fanconi's syndrome. Consistent
with this possibility is our recently reported observa-
tion [49] that in five nonazotemic children with Fan-
coni's syndrome, l,25(OH)2D3 was not detected in
the blood after administration of 3H-25(OH)D3, de-
spite the presence of hypophosphatemia, rickets,
and/or increased levels of circulating parathyroid
hormone, all of which are considered to be stimu-
lators of l,25(OH)2D3 synthesis [33, 44, 46, 50, 51].
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